首页> 外文期刊>Annals of surgical oncology >In Reply: Partial Hepatectomy for Colorectal Metastases and Perihepatic Lymph Node Micrometastases
【24h】

In Reply: Partial Hepatectomy for Colorectal Metastases and Perihepatic Lymph Node Micrometastases

机译:在答复中:部分肝切除术用于结直肠转移和肝周淋巴结微转移

获取原文
获取原文并翻译 | 示例
       

摘要

We appreciate Dr. Pandey's thoughtful comments on our article. As he remarks, it is encouraging that 3-year overall survival is 25% even for those patients with metastatic disease to perihepatic lymph nodes discovered by hematoxylin and eosin (H&E) staining after hepatectomy. Whether these lymph node deposits represent metastasis derived from the primary colorectal tumor or the liver tumors is uncertain. Dr. Pandey's statement that metastasis in perihepatic nodes derived from the primary tumor indicates more aggressive tumor biology is debatable. Indeed, perihepatic lymph node metastasis arising from liver tumors may be more virulent given that the disease in the liver already has proven metastatic potential. Furthermore, there is ample data in the literature demonstrating that presence of tumors in perihepatic nodes is a poor prognostic sign. We eagerly await molecular data which might further settle this question.
机译:我们感谢潘迪博士对我们的文章发表的深思熟虑的评论。正如他所说,令人鼓舞的是,即使对于那些在肝切除术后通过苏木精和曙红(H&E)染色发现肝周淋巴结转移的转移性疾病患者,其3年总生存率为25%。这些淋巴结沉积物是否代表源自原发性结肠直肠肿瘤或肝肿瘤的转移尚不确定。 Pandey博士的说法是原发性肿瘤在肝周淋巴结转移,这表明更具攻击性的肿瘤生物学值得商bat。的确,鉴于肝脏疾病已被证明具有转移潜力,因此肝肿瘤引起的肝周淋巴结转移可能更具毒性。此外,文献中有大量数据表明肝周淋巴结中存在肿瘤是不良的预后征兆。我们热切地等待着可能会进一步解决这个问题的分子数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号